HEADER TRANSFERASE/TRANSFERASE INHIBITOR 03-MAY-12 4F09 TITLE DISCOVERY AND OPTIMIZATION OF C-2 METHYL IMIDAZO-PYRROLOPYRIDINES AS TITLE 2 POTENT AND ORALLY BIOAVAILABLE JAK1 INHIBITORS WITH SELECTIVITY OVER TITLE 3 JAK2 COMPND MOL_ID: 1; COMPND 2 MOLECULE: TYROSINE-PROTEIN KINASE JAK2; COMPND 3 CHAIN: A; COMPND 4 FRAGMENT: UNP RESIDUES 833-1132; COMPND 5 SYNONYM: JANUS KINASE 2, JAK-2; COMPND 6 EC: 2.7.10.2; COMPND 7 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: JAK2 KINASE DOMAIN; SOURCE 6 EXPRESSION_SYSTEM: SPODOPTERA FRUGIPERDA; SOURCE 7 EXPRESSION_SYSTEM_COMMON: FALL ARMYWORM; SOURCE 8 EXPRESSION_SYSTEM_TAXID: 7108; SOURCE 9 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID KEYWDS JAK2, KINASE DOMAIN, JH1 DOMAIN, TRANSFERASE-TRANSFERASE INHIBITOR KEYWDS 2 COMPLEX EXPDTA X-RAY DIFFRACTION AUTHOR J.M.MURRAY REVDAT 4 06-DEC-23 4F09 1 REMARK REVDAT 3 13-SEP-23 4F09 1 REMARK SEQADV LINK REVDAT 2 25-JUL-12 4F09 1 JRNL REMARK REVDAT 1 04-JUL-12 4F09 0 JRNL AUTH M.ZAK,R.MENDONCA,M.BALAZS,K.BARRETT,P.BERGERON,W.S.BLAIR, JRNL AUTH 2 C.CHANG,G.DESHMUKH,J.DEVOSS,P.S.DRAGOVICH,C.EIGENBROT, JRNL AUTH 3 N.GHILARDI,P.GIBBONS,S.GRADL,C.HAMMAN,E.J.HANAN,E.HARSTAD, JRNL AUTH 4 P.R.HEWITT,C.A.HURLEY,T.JIN,A.JOHNSON,T.JOHNSON,J.R.KENNY, JRNL AUTH 5 M.F.KOEHLER,P.BIR KOHLI,J.J.KULAGOWSKI,S.LABADIE,J.LIAO, JRNL AUTH 6 M.LIIMATTA,Z.LIN,P.J.LUPARDUS,R.J.MAXEY,J.M.MURRAY,R.PULK, JRNL AUTH 7 M.RODRIGUEZ,S.SAVAGE,S.SHIA,M.STEFFEK,S.UBHAYAKAR,M.ULTSCH, JRNL AUTH 8 A.VAN ABBEMA,S.I.WARD,L.XIAO,Y.XIAO JRNL TITL DISCOVERY AND OPTIMIZATION OF C-2 METHYL JRNL TITL 2 IMIDAZOPYRROLOPYRIDINES AS POTENT AND ORALLY BIOAVAILABLE JRNL TITL 3 JAK1 INHIBITORS WITH SELECTIVITY OVER JAK2. JRNL REF J.MED.CHEM. V. 55 6176 2012 JRNL REFN ISSN 0022-2623 JRNL PMID 22698084 JRNL DOI 10.1021/JM300628C REMARK 2 REMARK 2 RESOLUTION. 2.40 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : BUSTER-TNT REMARK 3 AUTHORS : BRICOGNE,BLANC,BRANDL,FLENSBURG,KELLER, REMARK 3 : PACIOREK,ROVERSI,SMART,VONRHEIN,WOMACK, REMARK 3 : MATTHEWS,TEN EYCK,TRONRUD REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.40 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 49.28 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 COMPLETENESS FOR RANGE (%) : 99.7 REMARK 3 NUMBER OF REFLECTIONS : 11788 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.198 REMARK 3 R VALUE (WORKING SET) : 0.195 REMARK 3 FREE R VALUE : 0.254 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 4.880 REMARK 3 FREE R VALUE TEST SET COUNT : 575 REMARK 3 ESTIMATED ERROR OF FREE R VALUE : NULL REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 6 REMARK 3 BIN RESOLUTION RANGE HIGH (ANGSTROMS) : 2.40 REMARK 3 BIN RESOLUTION RANGE LOW (ANGSTROMS) : 2.63 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 99.70 REMARK 3 REFLECTIONS IN BIN (WORKING + TEST SET) : 2812 REMARK 3 BIN R VALUE (WORKING + TEST SET) : 0.1923 REMARK 3 REFLECTIONS IN BIN (WORKING SET) : 2659 REMARK 3 BIN R VALUE (WORKING SET) : 0.1889 REMARK 3 BIN FREE R VALUE : 0.2522 REMARK 3 BIN FREE R VALUE TEST SET SIZE (%) : 5.44 REMARK 3 BIN FREE R VALUE TEST SET COUNT : 153 REMARK 3 ESTIMATED ERROR OF BIN FREE R VALUE : NULL REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 2398 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 19 REMARK 3 SOLVENT ATOMS : 91 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 18.00 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 25.24 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : -6.81970 REMARK 3 B22 (A**2) : 2.87080 REMARK 3 B33 (A**2) : 3.94890 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 0.49500 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM LUZZATI PLOT (A) : 0.270 REMARK 3 DPI (BLOW EQ-10) BASED ON R VALUE (A) : NULL REMARK 3 DPI (BLOW EQ-9) BASED ON FREE R VALUE (A) : NULL REMARK 3 DPI (CRUICKSHANK) BASED ON R VALUE (A) : 0.548 REMARK 3 DPI (CRUICKSHANK) BASED ON FREE R VALUE (A) : NULL REMARK 3 REMARK 3 REFERENCES: BLOW, D. (2002) ACTA CRYST D58, 792-797 REMARK 3 CRUICKSHANK, D.W.J. (1999) ACTA CRYST D55, 583-601 REMARK 3 REMARK 3 CORRELATION COEFFICIENTS. REMARK 3 CORRELATION COEFFICIENT FO-FC : 0.906 REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : 0.828 REMARK 3 REMARK 3 NUMBER OF GEOMETRIC FUNCTION TERMS DEFINED : 15 REMARK 3 TERM COUNT WEIGHT FUNCTION. REMARK 3 BOND LENGTHS : 2452 ; 2.000 ; HARMONIC REMARK 3 BOND ANGLES : 3308 ; 2.000 ; HARMONIC REMARK 3 TORSION ANGLES : 874 ; 2.000 ; SINUSOIDAL REMARK 3 TRIGONAL CARBON PLANES : 69 ; 2.000 ; HARMONIC REMARK 3 GENERAL PLANES : 346 ; 5.000 ; HARMONIC REMARK 3 ISOTROPIC THERMAL FACTORS : 2452 ; 20.000 ; HARMONIC REMARK 3 BAD NON-BONDED CONTACTS : NULL ; NULL ; NULL REMARK 3 IMPROPER TORSIONS : NULL ; NULL ; NULL REMARK 3 PSEUDOROTATION ANGLES : NULL ; NULL ; NULL REMARK 3 CHIRAL IMPROPER TORSION : 296 ; 5.000 ; SEMIHARMONIC REMARK 3 SUM OF OCCUPANCIES : NULL ; NULL ; NULL REMARK 3 UTILITY DISTANCES : NULL ; NULL ; NULL REMARK 3 UTILITY ANGLES : NULL ; NULL ; NULL REMARK 3 UTILITY TORSION : NULL ; NULL ; NULL REMARK 3 IDEAL-DIST CONTACT TERM : 2892 ; 4.000 ; SEMIHARMONIC REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 BOND LENGTHS (A) : 0.009 REMARK 3 BOND ANGLES (DEGREES) : 1.21 REMARK 3 PEPTIDE OMEGA TORSION ANGLES (DEGREES) : 3.03 REMARK 3 OTHER TORSION ANGLES (DEGREES) : 19.40 REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 4F09 COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 11-MAY-12. REMARK 100 THE DEPOSITION ID IS D_1000072291. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 17-MAR-10 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 6 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : SSRL REMARK 200 BEAMLINE : BL7-1 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : NULL REMARK 200 WAVELENGTH OR RANGE (A) : 0.979 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : ADSC QUANTUM 315R REMARK 200 INTENSITY-INTEGRATION SOFTWARE : DENZO REMARK 200 DATA SCALING SOFTWARE : SCALEPACK REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 13267 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.400 REMARK 200 RESOLUTION RANGE LOW (A) : 50.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : 0.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 83.2 REMARK 200 DATA REDUNDANCY : 3.100 REMARK 200 R MERGE (I) : 0.09500 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 7.9000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.15 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.23 REMARK 200 COMPLETENESS FOR SHELL (%) : 33.0 REMARK 200 DATA REDUNDANCY IN SHELL : 1.60 REMARK 200 R MERGE FOR SHELL (I) : 0.28000 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : NULL REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: PHASER REMARK 200 STARTING MODEL: PDB ENTRY 2B7A REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 44.61 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.22 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 0.2 M AMMONIUM ACETATE, 0.1M SODIUM REMARK 280 CITRATE PH6, 20 % PEG 8000, VAPOR DIFFUSION, HANGING DROP, REMARK 280 TEMPERATURE 277K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 1 21 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 1.000000 0.000000 34.74500 REMARK 290 SMTRY3 2 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 GLY A 831 REMARK 465 SER A 832 REMARK 465 SER A 833 REMARK 465 GLY A 834 REMARK 465 ALA A 835 REMARK 465 PHE A 836 REMARK 465 GLU A 837 REMARK 465 ASP A 838 REMARK 465 ARG A 839 REMARK 465 ASP A 840 REMARK 465 PRO A 841 REMARK 465 THR A 842 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 ARG A 893 CG CD NE CZ NH1 NH2 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS REMARK 500 REMARK 500 THE FOLLOWING ATOMS THAT ARE RELATED BY CRYSTALLOGRAPHIC REMARK 500 SYMMETRY ARE IN CLOSE CONTACT. AN ATOM LOCATED WITHIN 0.15 REMARK 500 ANGSTROMS OF A SYMMETRY RELATED ATOM IS ASSUMED TO BE ON A REMARK 500 SPECIAL POSITION AND IS, THEREFORE, LISTED IN REMARK 375 REMARK 500 INSTEAD OF REMARK 500. ATOMS WITH NON-BLANK ALTERNATE REMARK 500 LOCATION INDICATORS ARE NOT INCLUDED IN THE CALCULATIONS. REMARK 500 REMARK 500 DISTANCE CUTOFF: REMARK 500 2.2 ANGSTROMS FOR CONTACTS NOT INVOLVING HYDROGEN ATOMS REMARK 500 1.6 ANGSTROMS FOR CONTACTS INVOLVING HYDROGEN ATOMS REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI SSYMOP DISTANCE REMARK 500 NH1 ARG A 922 NE2 GLN A 1072 2555 1.83 REMARK 500 CG2 THR A 875 OD2 ASP A 1096 2656 1.90 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND ANGLES REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,A3,1X,A1,I4,A1,3(1X,A4,2X),12X,F5.1) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 ATM2 ATM3 REMARK 500 LEU A 852 N - CA - C ANGL. DEV. = 17.1 DEGREES REMARK 500 LEU A 967 CA - CB - CG ANGL. DEV. = 16.2 DEGREES REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 PHE A 860 6.92 83.39 REMARK 500 GLN A 872 2.71 82.54 REMARK 500 ARG A 975 -3.17 70.26 REMARK 500 ASP A 976 38.57 -142.27 REMARK 500 REMARK 500 REMARK: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE JAK A 1201 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 4F08 RELATED DB: PDB REMARK 900 RELATED ID: 4EI4 RELATED DB: PDB REMARK 900 RELATED ID: 4EHZ RELATED DB: PDB DBREF 4F09 A 833 1132 UNP O60674 JAK2_HUMAN 833 1132 SEQADV 4F09 GLY A 831 UNP O60674 EXPRESSION TAG SEQADV 4F09 SER A 832 UNP O60674 EXPRESSION TAG SEQRES 1 A 302 GLY SER SER GLY ALA PHE GLU ASP ARG ASP PRO THR GLN SEQRES 2 A 302 PHE GLU GLU ARG HIS LEU LYS PHE LEU GLN GLN LEU GLY SEQRES 3 A 302 LYS GLY ASN PHE GLY SER VAL GLU MET CYS ARG TYR ASP SEQRES 4 A 302 PRO LEU GLN ASP ASN THR GLY GLU VAL VAL ALA VAL LYS SEQRES 5 A 302 LYS LEU GLN HIS SER THR GLU GLU HIS LEU ARG ASP PHE SEQRES 6 A 302 GLU ARG GLU ILE GLU ILE LEU LYS SER LEU GLN HIS ASP SEQRES 7 A 302 ASN ILE VAL LYS TYR LYS GLY VAL CYS TYR SER ALA GLY SEQRES 8 A 302 ARG ARG ASN LEU LYS LEU ILE MET GLU TYR LEU PRO TYR SEQRES 9 A 302 GLY SER LEU ARG ASP TYR LEU GLN LYS HIS LYS GLU ARG SEQRES 10 A 302 ILE ASP HIS ILE LYS LEU LEU GLN TYR THR SER GLN ILE SEQRES 11 A 302 CYS LYS GLY MET GLU TYR LEU GLY THR LYS ARG TYR ILE SEQRES 12 A 302 HIS ARG ASP LEU ALA THR ARG ASN ILE LEU VAL GLU ASN SEQRES 13 A 302 GLU ASN ARG VAL LYS ILE GLY ASP PHE GLY LEU THR LYS SEQRES 14 A 302 VAL LEU PRO GLN ASP LYS GLU PTR PTR LYS VAL LYS GLU SEQRES 15 A 302 PRO GLY GLU SER PRO ILE PHE TRP TYR ALA PRO GLU SER SEQRES 16 A 302 LEU THR GLU SER LYS PHE SER VAL ALA SER ASP VAL TRP SEQRES 17 A 302 SER PHE GLY VAL VAL LEU TYR GLU LEU PHE THR TYR ILE SEQRES 18 A 302 GLU LYS SER LYS SER PRO PRO ALA GLU PHE MET ARG MET SEQRES 19 A 302 ILE GLY ASN ASP LYS GLN GLY GLN MET ILE VAL PHE HIS SEQRES 20 A 302 LEU ILE GLU LEU LEU LYS ASN ASN GLY ARG LEU PRO ARG SEQRES 21 A 302 PRO ASP GLY CYS PRO ASP GLU ILE TYR MET ILE MET THR SEQRES 22 A 302 GLU CYS TRP ASN ASN ASN VAL ASN GLN ARG PRO SER PHE SEQRES 23 A 302 ARG ASP LEU ALA LEU ARG VAL ASP GLN ILE ARG ASP ASN SEQRES 24 A 302 MET ALA GLY MODRES 4F09 PTR A 1007 TYR O-PHOSPHOTYROSINE MODRES 4F09 PTR A 1008 TYR O-PHOSPHOTYROSINE HET PTR A1007 16 HET PTR A1008 16 HET JAK A1201 19 HETNAM PTR O-PHOSPHOTYROSINE HETNAM JAK 2-METHYL-1-(PIPERIDIN-4-YL)-1,6-DIHYDROIMIDAZO[4,5- HETNAM 2 JAK D]PYRROLO[2,3-B]PYRIDINE HETSYN PTR PHOSPHONOTYROSINE FORMUL 1 PTR 2(C9 H12 N O6 P) FORMUL 2 JAK C14 H17 N5 FORMUL 3 HOH *91(H2 O) HELIX 1 1 GLU A 845 ARG A 847 5 3 HELIX 2 2 THR A 888 SER A 904 1 17 HELIX 3 3 SER A 919 ARG A 923 1 5 HELIX 4 4 SER A 936 HIS A 944 1 9 HELIX 5 5 ASP A 949 LYS A 970 1 22 HELIX 6 6 ALA A 978 ARG A 980 5 3 HELIX 7 7 PRO A 1017 TYR A 1021 5 5 HELIX 8 8 ALA A 1022 SER A 1029 1 8 HELIX 9 9 SER A 1032 THR A 1049 1 18 HELIX 10 10 GLU A 1052 LYS A 1055 5 4 HELIX 11 11 SER A 1056 GLY A 1066 1 11 HELIX 12 12 GLY A 1071 ASN A 1084 1 14 HELIX 13 13 PRO A 1095 TRP A 1106 1 12 HELIX 14 14 ASN A 1109 ARG A 1113 5 5 HELIX 15 15 SER A 1115 GLY A 1132 1 18 SHEET 1 A 5 LEU A 849 GLY A 856 0 SHEET 2 A 5 SER A 862 TYR A 868 -1 O MET A 865 N GLN A 853 SHEET 3 A 5 GLU A 877 LYS A 883 -1 O GLU A 877 N TYR A 868 SHEET 4 A 5 ASN A 924 GLU A 930 -1 O MET A 929 N ALA A 880 SHEET 5 A 5 TYR A 913 TYR A 918 -1 N GLY A 915 O ILE A 928 SHEET 1 B 2 TYR A 972 ILE A 973 0 SHEET 2 B 2 LYS A 999 VAL A1000 -1 O LYS A 999 N ILE A 973 SHEET 1 C 2 ILE A 982 ASN A 986 0 SHEET 2 C 2 ARG A 989 ILE A 992 -1 O LYS A 991 N LEU A 983 SHEET 1 D 2 PTR A1008 LYS A1009 0 SHEET 2 D 2 LYS A1030 PHE A1031 -1 O PHE A1031 N PTR A1008 LINK C GLU A1006 N PTR A1007 1555 1555 1.32 LINK C PTR A1007 N PTR A1008 1555 1555 1.33 LINK C PTR A1008 N LYS A1009 1555 1555 1.31 CISPEP 1 GLY A 858 ASN A 859 0 7.04 SITE 1 AC1 10 GLY A 856 VAL A 863 ALA A 880 MET A 929 SITE 2 AC1 10 GLU A 930 TYR A 931 LEU A 932 GLY A 935 SITE 3 AC1 10 LEU A 983 HOH A1323 CRYST1 44.440 69.490 50.230 90.00 101.17 90.00 P 1 21 1 2 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.022502 0.000000 0.004443 0.00000 SCALE2 0.000000 0.014391 0.000000 0.00000 SCALE3 0.000000 0.000000 0.020293 0.00000